• Homepage
  • Modernize Biopharmaceutical Quality Control Testing

Modernize Biopharmaceutical Quality Control Testing

Introduction

Quality control of biological products to support clinical trials and post market assay activities require the evaluation of multiple critical product attributes.

The evaluation can include functional assessment for specificity to a target receptor, titer and other quality attributes such as glycosylation, Fc receptor molecule binding, stability assessment to check for the formation of aggregates, etc.

The Octet® platform provides a comprehensive screening and characterization tool across a diverse range of applications during drug development and is especially versatile in antibody and protein quantitation, contaminant testing and general product characterization. This platform circumvents the limitations of ELISA and HPLC platforms, enabling informed decisions to be made earlier in bioprocess development.

Complete the form to download the application note